Novel
ALK
Fusion,
PPFIBP1-ALK
, in Pancreatic Ductal Adenocarcinoma Responsive to Alectinib and Lorlatinib
JCO Precis Oncol
.
2020 Jul 27:4:PO.19.00365.
doi: 10.1200/PO.19.00365.
eCollection 2020.
Authors
Arjan Gower
1
1
,
Barry Golestany
2
,
Jun Gong
3
,
Aatur D Singhi
4
,
Andrew Eugene Hendifar
3
Affiliations
1
Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA.
2
Department of Radiology, Cedars Sinai Medical Center, Los Angeles, CA.
3
Division of Hematology and Oncology, Cedars Sinai Medical Center, Los Angeles, CA.
4
Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA.
PMID:
32923899
PMCID:
PMC7446504
DOI:
10.1200/PO.19.00365
No abstract available
Publication types
Case Reports